23andMe Gets FDA Approval for a DNA Cancer Test- It will now be able to tell customers if they have 2 genetic variants that influence MUTYH-associated polyposis, a rare condition associated with an increased risk of colorectal cancer.

23andMe Gets FDA Approval for a DNA Cancer Test- It will now be able to tell customers if they have 2 genetic variants that influence MUTYH-associated polyposis, a rare condition associated with an increased risk of colorectal cancer.: http://bit.ly/2Dso6OP Read more... http://bit.ly/2DvJymh